Michael D. Hooven, Director at AtriCure, Inc. (ATRC), sold 30,000 shares at $14.00 ($420K) on 2011-06-13, disclosed to the SEC on 2011-06-14.
Open-market sale of $420k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |